Literature DB >> 3964932

Infected aortoiliofemoral grafts: magnetic resonance imaging.

E Justich, E G Amparo, H Hricak, C B Higgins.   

Abstract

Three patients with proved infected aortoiliofemoral grafts were examined by magnetic resonance (MR) imaging using a spin echo technique. MR clearly identified the perigraft abscess, the involvement of adjacent structures, and the longitudinal extent of the process in all patients. The MR findings were: Abscesses create a high signal intensity, somewhat less than fat. The perigraft abscess has a great contrast with the signal void of flowing blood in the graft. Inflammatory changes cause an inhomogeneous intermediate signal, slightly more intense than muscle. Both abscesses and edematous areas increase their signal intensity with long repetition rates and long echo delays. Areas of gas appear black. They cannot be distinguished from calcified plaques. Additional information is gained about the graft patency. Although the specificity has to be proved, MR imaging is sensitive in the detection of infected grafts and for defining the longitudinal extent of the perigraft abscess.

Entities:  

Mesh:

Year:  1985        PMID: 3964932     DOI: 10.1148/radiology.154.1.3964932

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  The 111In-granulocyte scan in prosthetic vascular graft infections: imaging technique and results.

Authors:  W Becker; W Düsel; P Berger; W Spiegel
Journal:  Eur J Nucl Med       Date:  1987

2.  Magnetic resonance applications in atherosclerotic vascular disease.

Authors:  G E Wesbey; C B Higgins; J D Hale; P E Valk
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

3.  STIR imaging of synthetic vascular graft infection.

Authors:  M E Hansen; E K Yucel; A C Waltman
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Jan-Feb       Impact factor: 2.740

4.  Ga-67 citrate scan in vascular graft infection.

Authors:  I Banzo; R Quirce; J Serrano; J Jimenez; O Tabuenca; J M Carril
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.